These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 1965792

  • 1. Bone marrow transplantation for the treatment of immune deficiency states.
    Lenarsky C, Parkman R.
    Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

  • 6. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A, Verardi R, Tettoni K, Neva A, Mazzolari E, Pennacchio M, Pasic S, Ugazio AG, Albertini A, Porta F.
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [Abstract] [Full Text] [Related]

  • 7. Hematopoietic stem cell transplantation for primary lymphoid immunodeficiencies.
    Kapoor N, Crooks G, Kohn DB, Parkman R.
    Semin Hematol; 1998 Oct; 35(4):346-53. PubMed ID: 9801263
    [Abstract] [Full Text] [Related]

  • 8. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    Parkman R, Rappeport J, Geha R, Belli J, Cassady R, Levey R, Nathan DG, Rosen FS.
    N Engl J Med; 1978 Apr 27; 298(17):921-7. PubMed ID: 347289
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
    Filipovich AH.
    Transfus Sci; 1991 Apr 27; 12(3):135-42. PubMed ID: 10149543
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J.
    Verh K Acad Geneeskd Belg; 1998 Apr 27; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [Abstract] [Full Text] [Related]

  • 12. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL, Volkman DJ, Buckley RH.
    J Immunol; 1989 Sep 01; 143(5):1575-9. PubMed ID: 2474604
    [Abstract] [Full Text] [Related]

  • 13. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L.
    Bone Marrow Transplant; 1991 Jan 01; 7(1):23-33. PubMed ID: 2043874
    [Abstract] [Full Text] [Related]

  • 14. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.
    Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Güngör T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I.
    Pediatrics; 2008 Sep 01; 122(3):e778-82. PubMed ID: 18762514
    [Abstract] [Full Text] [Related]

  • 15. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE, Buckley RH.
    J Immunol; 1987 Apr 01; 138(7):2088-94. PubMed ID: 2881966
    [Abstract] [Full Text] [Related]

  • 16. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 01; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 17. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA, Jerabek L, Edwards CT, Weissman IL.
    Biol Blood Marrow Transplant; 1996 Feb 01; 2(1):3-14. PubMed ID: 9078349
    [Abstract] [Full Text] [Related]

  • 20. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
    Kobayashi R, Ariga T, Nonoyama S, Kanegane H, Tsuchiya S, Morio T, Yabe H, Nagatoshi Y, Kawa K, Tabuchi K, Tsuchida M, Miyawaki T, Kato S.
    Br J Haematol; 2006 Nov 01; 135(3):362-6. PubMed ID: 17032176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.